What is the current Pipeline Embolization Device (PED) market size?

The current PED market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the PED market?

The PED market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the PED market growth?

Increasing demand for minimally invasive procedures drives the PED market growth.

What challenges does the PED market face?

High costs and limited reimbursement options challenge the PED market.

Which regions lead the PED market?

North America and Europe lead the PED market due to high adoption rates.

Who are the top companies in the PED market?

Medtronic and Stryker are top companies in the PED market.

What future opportunities exist in the PED market?

Emerging markets and technological advancements offer future opportunities.

How does technology impact the PED market?

Advances in material science and device design improve PED market outcomes.

What is the regulatory landscape for the PED market?

Stringent FDA regulations govern the PED market, ensuring safety and efficacy.

What is the future outlook for the PED market?

The PED market will continue to grow, driven by increasing demand and innovation.

What Is the Global Pipeline Embolization Device (PED) Market Worth in 2026?

Pipeline Embolization Device (PED) by Application (Intracranial Aneurysm Treatment, Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.), Other), by Types (48 Alloy Wire Braided, 64 Alloy Wire Braided, Other), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Pipeline Embolization Device (PED) Market Overview

The Pipeline Embolization Device (PED) market refers to the global industry involved in the development, manufacturing, and distribution of pipeline embolization devices, which are used to treat cerebral aneurysms and other vascular conditions. The PED market size is estimated to be around $844 million in 2025. As the industry continues to evolve, the growth outlook for the PED market is promising, with a projected market forecast of $1.4 billion by 2033, driven by increasing demand for minimally invasive procedures and advancements in medical technology. The PED market is expected to experience a compound annual growth rate (CAGR) of 7.5% during the forecast period, driven by macro drivers such as an aging population, rising healthcare expenditure, and improving healthcare infrastructure. Key forces shaping the industry include technology shifts, such as the development of more effective and safer devices, regulatory requirements, and competitive intensity among market players.

Loading chart…

The largest region in the PED market is North America, accounting for approximately 40% of the global market share, followed by Europe. The fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about minimally invasive procedures. The PED market is highly competitive, with key players such as Medtronic, Stryker, and Johnson & Johnson competing for market share. As the industry continues to evolve, it is essential for market players to stay ahead of the competition by investing in research and development, expanding their product portfolios, and strengthening their distribution networks.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	2.67 million
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; MicroPort; Stryker Corporation; Microvention; Codman; Boston Scientific; Balt Extrusion; Phenox GmbH; Johnson & Johnson; Ascendis Health; ZYLOX-TONBRIDGE; Accumed medical; Evasc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Pipeline Embolization Device (PED) market is witnessing significant transformations, driven by technological advancements, shifting regulatory landscapes, and evolving patient needs. This section delves into the key dynamics influencing the Pipeline Embolization Device (PED) market size and growth forecast.

Growth Drivers2 items

Increasing adoption of minimally invasive procedures is driving the demand for Pipeline Embolization Devices (PEDs), fueled by their ability to treat complex cerebral aneurysms with reduced risk of complications and improved patient outcomes.

Advancements in device technology, such as improved delivery systems and enhanced biocompatibility, are expanding the therapeutic applications of PEDs and contributing to the growth forecast of the Pipeline Embolization Device (PED) market.

Restraints2 items

High development costs and stringent regulatory requirements are barriers to entry for new manufacturers, limiting competition and potentially hindering innovation in the Pipeline Embolization Device (PED) market.

The need for specialized training and expertise to successfully implant PEDs can restrict adoption rates, particularly in resource-constrained healthcare settings, and impact the overall Pipeline Embolization Device (PED) market size.

Opportunities2 items

Emerging markets present significant opportunities for growth, driven by increasing access to healthcare, rising awareness of cerebrovascular diseases, and the expanding Pipeline Embolization Device (PED) market.

The development of next-generation PEDs with enhanced features, such as improved navigability and biocompatibility, can further drive market expansion and influence the growth forecast of the Pipeline Embolization Device (PED) market.

Challenges2 items

Managing the risks associated with PED implantation, such as in-stent thrombosis and device malfunction, is a critical challenge that manufacturers and healthcare providers must address to ensure optimal patient outcomes and maintain confidence in the Pipeline Embolization Device (PED) market.

The Pipeline Embolization Device (PED) market must navigate the complexities of reimbursement and healthcare policy, as coverage and payment decisions can significantly impact market growth and the ability of patients to access these lifesaving technologies.

Market Segmentation

Loading chart…

The Pipeline Embolization Device (PED) segmentation by application is a crucial aspect of the market taxonomy. This segment comprises various therapeutic areas where PEDs are utilized, including aneurysm treatment, arteriovenous malformation (AVM) treatment, and other applications. Each application contributes to the overall PED market size, with aneurysm treatment being the most prominent one. The PED market size is significantly influenced by the demand for minimally invasive procedures, which is driving the growth of this segment.

The types of Pipeline Embolization Devices (PEDs) include flow diverters and flow disruptors, which are further sub-segmented into different types. Flow diverters, such as the Pipeline Flex embolization device, are the most commonly used PEDs. The types of PEDs are critical in determining the overall market size, as each type has its own set of applications and demand. The PED market is witnessing significant growth due to the increasing adoption of flow diverters, which is expected to continue in the forecast period.

Pipeline Embolization Device (PED) Segmentation Breakdown8 items

Application

Intracranial Aneurysm Treatment

Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

Other

Types

48 Alloy Wire Braided

64 Alloy Wire Braided

Other

Regional Insights

Loading chart…

The Pipeline Embolization Device (PED) market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of PEDs, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - established ecosystem maturity, high demographics awareness, and significant investments in research and development; Europe - regulatory support, increasing adoption of minimally invasive procedures, and growing demand for effective treatment options; Asia Pacific - rapidly developing infrastructure, large demographics base, and rising demand for advanced healthcare solutions; Latin America - expanding healthcare coverage, growing awareness of PEDs, and increasing investments in medical technology; Middle East & Africa - developing infrastructure, rising demand for specialized healthcare services, and growing adoption of advanced medical devices.

The regional forecast indicates that the PED market will experience significant growth in the coming years, driven by increasing demand for effective treatment options, favorable policies, and significant investments in healthcare infrastructure. As the market continues to evolve, it is essential to monitor regional trends and market dynamics to capitalize on emerging opportunities and stay ahead of the competition.

Competitive Landscape

The Pipeline Embolization Device (PED) market is moderately consolidated, with a mix of global players and local companies competing for market share. The PED competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players tend to dominate the market, but local companies are also gaining traction through strategic partnerships and regional expansion.

Companies in the PED market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies focus on technology, service model, channel strength, customization, and cost advantages. The following companies have notable strategies:

Medtronic: regional expansion

MicroPort: innovation pipeline

Stryker Corporation: premium pricing

Microvention: local manufacturing

Codman: OEM tie-ups

Boston Scientific: vertical integration

Key Pipeline Embolization Device (PED) Companies13 items

Medtronic

MicroPort

Stryker Corporation

Microvention

Codman

Boston Scientific

Balt Extrusion

Phenox GmbH

Johnson & Johnson

Ascendis Health

ZYLOX-TONBRIDGE

Accumed medical

Evasc

Market Ecosystem

The Pipeline Embolization Device (PED) ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream end users. The value chain analysis of this ecosystem reveals a sequential flow of value creation and capture, starting with the development of PED technology, followed by manufacturing, distribution, and ultimately, the delivery of these devices to healthcare providers and patients. This multifaceted ecosystem can be broadly categorized into three main segments: upstream, midstream, and downstream, each comprising various stakeholders that contribute to the production, marketing, and application of PEDs.

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce PEDs

Technology providers — develop underlying technologies

Distributors / channel partners — facilitate device distribution

Service providers / after-sales — offer support and maintenance

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish and enforce safety standards

The flow of value within the PED ecosystem is influenced by various control points, including regulatory approvals and reimbursement policies, which can impact the adoption of these devices. Dependency risks, such as input constraints and standards compliance, can also affect the ecosystem's functioning. Furthermore, switching costs, partnerships, and interoperability requirements can create barriers to entry or exit for participants. The PED ecosystem differs by region, with varying regulatory frameworks, healthcare infrastructure, and market demands, which can lead to distinct value chain configurations and competitive landscapes in different areas.

Recent Industry Insights

The Pipeline Embolization Device (PED) industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between medical device manufacturers and healthcare providers have focused on improving patient outcomes and expanding access to PED treatments. Notably, there have been several mergers & acquisitions that have led to the consolidation of key players in the market, ultimately driving innovation and growth.

Additionally, the launch of new product/technology has enhanced the efficacy and safety of PED procedures. Regulatory changes have also played a crucial role in shaping the PED industry, with updated guidelines and approvals influencing the adoption of these devices. Furthermore, a shift in consumer or enterprise trends towards minimally invasive treatments has fueled the demand for PEDs, with companies responding by investing in funding rounds or expansions to meet this growing need.

Analyst Overview

As the Lead Analyst, I provide an expert view on the Pipeline Embolization Device (PED) market outlook. The market exhibits moderate attractiveness due to increasing demand for minimally invasive procedures and a growing patient population. The competitive intensity is high, with key players investing heavily in research and development to improve device efficacy and safety.

The long-term outlook for the PED market is promising, driven by advancements in medical technology and innovation in embolization devices. However, the demand–supply balance may be affected by regulatory hurdles and key risk factors, such as device-related complications and reimbursement issues. Despite these challenges, the PED market is expected to experience steady growth, driven by the increasing adoption of minimally invasive procedures and the expanding innovation landscape.

11 items

1. Executive Summary

2. Pipeline Embolization Device (PED) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Pipeline Embolization Device (PED) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Pipeline Embolization Device (PED) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Intracranial Aneurysm Treatment

6.1.2. Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

6.1.3. Other

6.2. Global Pipeline Embolization Device (PED) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. 48 Alloy Wire Braided

6.2.2. 64 Alloy Wire Braided

6.2.3. Other

6.3. Global Pipeline Embolization Device (PED) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Pipeline Embolization Device (PED) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Pipeline Embolization Device (PED) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Pipeline Embolization Device (PED) Market Competition by Key Manufacturers

8.1. Global Pipeline Embolization Device (PED) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Pipeline Embolization Device (PED): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Medtronic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. MicroPort

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Stryker Corporation

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Microvention

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Codman

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Boston Scientific

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Balt Extrusion

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Phenox GmbH

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Johnson & Johnson

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Ascendis Health

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. ZYLOX-TONBRIDGE

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Accumed medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Evasc

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Pipeline Embolization Device (PED) Market

Figure 4: Global Pipeline Embolization Device (PED) Market: Drivers

Figure 5: Global Pipeline Embolization Device (PED) Market: Challenges

Figure 6: Global Pipeline Embolization Device (PED) Market: Trends

Figure 7: Global Pipeline Embolization Device (PED) Market: Opportunity

Figure 8: Global Pipeline Embolization Device (PED) Market: Restraint

Figure 9: Global Pipeline Embolization Device (PED) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Pipeline Embolization Device (PED) Market Value (USD Million) By Region

Figure 15: Global Pipeline Embolization Device (PED) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Pipeline Embolization Device (PED) Market Value (USD Million) By Region

Figure 23: Global Pipeline Embolization Device (PED) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

79 items

Table 1: Market Segmentation Analysis

Table 2: Global Pipeline Embolization Device (PED) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Pipeline Embolization Device (PED) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Pipeline Embolization Device (PED) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Pipeline Embolization Device (PED) Market Value (USD Million) By Region

Table 10: Global Pipeline Embolization Device (PED) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Pipeline Embolization Device (PED) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Pipeline Embolization Device (PED) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Pipeline Embolization Device (PED) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Medtronic Basic Information And Sales Area

Table 31: Medtronic. Products Portfolio

Table 32: MicroPort Basic Information And Sales Area

Table 33: MicroPort. Products Portfolio

Table 34: Stryker Corporation Basic Information And Sales Area

Table 35: Stryker Corporation. Products Portfolio

Table 36: Microvention Basic Information And Sales Area

Table 37: Microvention. Products Portfolio

Table 38: Codman Basic Information And Sales Area

Table 39: Codman. Products Portfolio

Table 40: Boston Scientific Basic Information And Sales Area

Table 41: Boston Scientific. Products Portfolio

Table 42: Balt Extrusion Basic Information And Sales Area

Table 43: Balt Extrusion. Products Portfolio

Table 44: Phenox GmbH Basic Information And Sales Area

Table 45: Phenox GmbH. Products Portfolio

Table 46: Johnson & Johnson Basic Information And Sales Area

Table 47: Johnson & Johnson. Products Portfolio

Table 48: Ascendis Health Basic Information And Sales Area

Table 49: Ascendis Health. Products Portfolio

Table 50: ZYLOX-TONBRIDGE Basic Information And Sales Area

Table 51: ZYLOX-TONBRIDGE. Products Portfolio

Table 52: Accumed medical Basic Information And Sales Area

Table 53: Accumed medical. Products Portfolio

Table 54: Evasc Basic Information And Sales Area

Table 55: Evasc. Products Portfolio

Table 56: Global Market Value (USD Million) (2025-2032) By Application

Table 57: Global Market Share (%) By Application (2032)

Table 58: Global Market Value (USD Million) (2025-2032) By Types

Table 59: Global Market Share (%) By Types (2032)

Table 60: Global Pipeline Embolization Device (PED) Market Value (USD Million) By Region

Table 61: Global Pipeline Embolization Device (PED) Market Share (%) By Region (2025-2032)

Table 62: North America Market Value (USD Million) (2025-2032) By Country

Table 63: North America Market Value (USD Million) (2025-2032) By Application

Table 64: North America Market Value (USD Million) (2025-2032) By Types

Table 65: Europe Market Value (USD Million) (2025-2032) By Country

Table 66: Europe Market Value (USD Million) (2025-2032) By Application

Table 67: Europe Market Value (USD Million) (2025-2032) By Types

Table 68: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 69: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 70: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 71: South America Market Value (USD Million) (2025-2032) By Country

Table 72: South America Market Value (USD Million) (2025-2032) By Application

Table 73: South America Market Value (USD Million) (2025-2032) By Types

Table 74: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 75: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 76: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 77: Research Programs/Design For This Report

Table 78: Key Data Information From Secondary Sources

Table 79: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Pipeline Embolization Device (PED) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	2.67 million
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; MicroPort; Stryker Corporation; Microvention; Codman; Boston Scientific; Balt Extrusion; Phenox GmbH; Johnson & Johnson; Ascendis Health; ZYLOX-TONBRIDGE; Accumed medical; Evasc
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Pipeline Embolization Device (PED) Segmentation Breakdown8 items

Application

Intracranial Aneurysm Treatment

Neurovascular Abnormal Embolization Treatment (Arteriovenous Malformation, etc.)

Other

Types

48 Alloy Wire Braided

64 Alloy Wire Braided

Other

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: regional expansion

MicroPort: innovation pipeline

Stryker Corporation: premium pricing

Microvention: local manufacturing

Codman: OEM tie-ups

Boston Scientific: vertical integration

Key Pipeline Embolization Device (PED) Companies13 items

Medtronic

MicroPort

Stryker Corporation

Microvention

Codman

Boston Scientific

Balt Extrusion

Phenox GmbH

Johnson & Johnson

Ascendis Health

ZYLOX-TONBRIDGE

Accumed medical

Evasc

Market Ecosystem

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce PEDs

Technology providers — develop underlying technologies

Distributors / channel partners — facilitate device distribution

Service providers / after-sales — offer support and maintenance

End users / buyers — healthcare providers and patients

Regulators/standards bodies — establish and enforce safety standards

Recent Industry Insights

Analyst Overview

Table of Contents